Matches in SemOpenAlex for { <https://semopenalex.org/work/W1963806424> ?p ?o ?g. }
- W1963806424 endingPage "48" @default.
- W1963806424 startingPage "41" @default.
- W1963806424 abstract "Abstract Enhanced delivery of doxorubicin (DXR) to colon 26 in mice was studied by the long-circulating liposomes (LCL) composed of distearoylphosphatidylcholine cholesterol (DSPC CH) (1 1. m m) and 6 mol° distearoyl phosphatidyl ethanolamine (DSPE) derivatives of poly(ethylene glycol) (PEG) with an average molecular weight of 1000. LCL was approximately 100 nm in mean diameter and encapsulated DXR with > 98% entrapping efficiency by the transmembrane pH gradient method. The control liposomes (LP) which had the same lipid composition, similar size and DXR entrapment as LCL. but did not have amphipathic PEG. were used for comparison. Liposomal DXR and free DXR were injected intravenously at a dose of 5 mg DXR kg to Balb c mice implanted subcutaneously with colon 26 carcinoma. DXR encapsulated in LCL showed high blood levels up to 24 h after injection, compared with the corresponding DXR-LP and free DXR. The value of the area under the curve (AUC) of blood was approximately 2.4-or 810-fold higher than that of DXR-LP or free DXR. respectively. LCL decreased the uptake amount of DXR by the reticuloendothelial system (RES) of liver and spleen. Both liposomal formulations effectively reduced the DXR concentrations in heart compared with free DXR. Compared with DXR-LP or free drug. DXR-LCL produced an approximately 3.6-or 10.5-fold increased DXR level in tumor. respectively, at 6 h after injection. The AUC value of tumor tissue for DXR-LCL was 3.4-or 9.4-fold higher than that of DXR-LP or free DXR. respectively. These high tumor levels of DXR by LCL corresponded to the prolonged residence feature of liposomes. Therapeutic experiments were performed with three different formulations of DXR. Administration of DXR-LCL at a dose of 10 mg DXR kg resulted in effective retardation of tumor growth and 2-fold prolongation of survival times compared with DXR-LP. free drug and saline. Our results indicate that DXR encapsulated in long-circulating liposomes is significantly more active against colon 26 carcinoma than the conventional liposome (DSPC CH. 1:1. m m) formulation of DXR and free drug. Thus long-circulating liposomes should be useful carriers of chemotherapeutic agents for the treatment of solid tumor." @default.
- W1963806424 created "2016-06-24" @default.
- W1963806424 creator A5024551314 @default.
- W1963806424 creator A5045164231 @default.
- W1963806424 creator A5050248299 @default.
- W1963806424 creator A5068273090 @default.
- W1963806424 creator A5076196980 @default.
- W1963806424 creator A5090415080 @default.
- W1963806424 date "1995-12-01" @default.
- W1963806424 modified "2023-09-24" @default.
- W1963806424 title "Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol)" @default.
- W1963806424 cites W1967838912 @default.
- W1963806424 cites W1970239046 @default.
- W1963806424 cites W1980775178 @default.
- W1963806424 cites W1987136303 @default.
- W1963806424 cites W2005556449 @default.
- W1963806424 cites W2027696154 @default.
- W1963806424 cites W2039884231 @default.
- W1963806424 cites W2050202061 @default.
- W1963806424 cites W2054889106 @default.
- W1963806424 cites W2105085256 @default.
- W1963806424 cites W2117808908 @default.
- W1963806424 cites W2161580101 @default.
- W1963806424 cites W2433294019 @default.
- W1963806424 doi "https://doi.org/10.1016/0378-5173(95)04074-9" @default.
- W1963806424 hasPublicationYear "1995" @default.
- W1963806424 type Work @default.
- W1963806424 sameAs 1963806424 @default.
- W1963806424 citedByCount "48" @default.
- W1963806424 countsByYear W19638064242012 @default.
- W1963806424 countsByYear W19638064242013 @default.
- W1963806424 countsByYear W19638064242014 @default.
- W1963806424 countsByYear W19638064242020 @default.
- W1963806424 crossrefType "journal-article" @default.
- W1963806424 hasAuthorship W1963806424A5024551314 @default.
- W1963806424 hasAuthorship W1963806424A5045164231 @default.
- W1963806424 hasAuthorship W1963806424A5050248299 @default.
- W1963806424 hasAuthorship W1963806424A5068273090 @default.
- W1963806424 hasAuthorship W1963806424A5076196980 @default.
- W1963806424 hasAuthorship W1963806424A5090415080 @default.
- W1963806424 hasConcept C10138342 @default.
- W1963806424 hasConcept C126322002 @default.
- W1963806424 hasConcept C13245373 @default.
- W1963806424 hasConcept C15920480 @default.
- W1963806424 hasConcept C162324750 @default.
- W1963806424 hasConcept C178790620 @default.
- W1963806424 hasConcept C185154212 @default.
- W1963806424 hasConcept C185592680 @default.
- W1963806424 hasConcept C2776694085 @default.
- W1963806424 hasConcept C2777516009 @default.
- W1963806424 hasConcept C2779820397 @default.
- W1963806424 hasConcept C2781303535 @default.
- W1963806424 hasConcept C43617362 @default.
- W1963806424 hasConcept C521977710 @default.
- W1963806424 hasConcept C54400483 @default.
- W1963806424 hasConcept C55493867 @default.
- W1963806424 hasConcept C67407626 @default.
- W1963806424 hasConcept C71924100 @default.
- W1963806424 hasConcept C77281830 @default.
- W1963806424 hasConcept C98274493 @default.
- W1963806424 hasConceptScore W1963806424C10138342 @default.
- W1963806424 hasConceptScore W1963806424C126322002 @default.
- W1963806424 hasConceptScore W1963806424C13245373 @default.
- W1963806424 hasConceptScore W1963806424C15920480 @default.
- W1963806424 hasConceptScore W1963806424C162324750 @default.
- W1963806424 hasConceptScore W1963806424C178790620 @default.
- W1963806424 hasConceptScore W1963806424C185154212 @default.
- W1963806424 hasConceptScore W1963806424C185592680 @default.
- W1963806424 hasConceptScore W1963806424C2776694085 @default.
- W1963806424 hasConceptScore W1963806424C2777516009 @default.
- W1963806424 hasConceptScore W1963806424C2779820397 @default.
- W1963806424 hasConceptScore W1963806424C2781303535 @default.
- W1963806424 hasConceptScore W1963806424C43617362 @default.
- W1963806424 hasConceptScore W1963806424C521977710 @default.
- W1963806424 hasConceptScore W1963806424C54400483 @default.
- W1963806424 hasConceptScore W1963806424C55493867 @default.
- W1963806424 hasConceptScore W1963806424C67407626 @default.
- W1963806424 hasConceptScore W1963806424C71924100 @default.
- W1963806424 hasConceptScore W1963806424C77281830 @default.
- W1963806424 hasConceptScore W1963806424C98274493 @default.
- W1963806424 hasFunder F4320320912 @default.
- W1963806424 hasIssue "1-2" @default.
- W1963806424 hasLocation W19638064241 @default.
- W1963806424 hasOpenAccess W1963806424 @default.
- W1963806424 hasPrimaryLocation W19638064241 @default.
- W1963806424 hasRelatedWork W1544960011 @default.
- W1963806424 hasRelatedWork W1551030083 @default.
- W1963806424 hasRelatedWork W1963806424 @default.
- W1963806424 hasRelatedWork W1980775178 @default.
- W1963806424 hasRelatedWork W2050614342 @default.
- W1963806424 hasRelatedWork W2082786939 @default.
- W1963806424 hasRelatedWork W2093442802 @default.
- W1963806424 hasRelatedWork W2112485061 @default.
- W1963806424 hasRelatedWork W2323591151 @default.
- W1963806424 hasRelatedWork W2183136778 @default.
- W1963806424 hasVolume "126" @default.
- W1963806424 isParatext "false" @default.
- W1963806424 isRetracted "false" @default.